Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.

Free
Message: In my

greeneyes / Re: In my

in response to by
posted on Mar 14, 2008 11:23AM

I would wager you, BUT, I think the transition from Turley to Goerner has/had EVERYTHING to do with M&A status/opportunity, so I'm inclined to agree with your timeframe, and almost stated as much at the time of the Goerner appointment. However, with this company, you never really can tell, so I've decided to withhold comment on Goerner/Turley.

I do think today's filing is an important first step, and if the BOD wants to show they are done playing games, they will step up with some independent open market purchasing as soon as it is allowed. Until they do that, IMO, they are approaching PTSC as though there is still HUGE risk, and thus the market accepts that as well. Time to put their money where their mouth is IMO.

Share
New Message
Please login to post a reply